PCSK9 Mechanism Lends Confidence Ahead Of Outcomes Data

With a well-defined mechanism of action and positive post hoc outcomes data, PCSK9 inhibitors possess a profile that raises the bar for other non-statin classes – CETP in particular.

More from Clinical Trials

More from R&D